The AllSci BriefFree, systematic R&D and deal news. Daily.
FDA approves Welireg and Lenvima combination for advanced renal cell carcinoma. Learn about this breakthrough treatment for ...
BigHat Biosciences secures $75M Series C to advance AI-designed protein therapeutics. Total funding reaches $223M. Discover ...
XtalPi files FDA IND application for KQTD-126, a gut-restricted pan-TRK inhibitor for chronic intestinal pain. First-in-class ...
Addex Therapeutics regains full global rights to GABAB PAM portfolio from Indivior. Collaboration termination follows ...
Celldex reports positive Phase 3 results for barzolvolimab in chronic urticaria, meeting primary endpoints. Read the ...
US Treasury drafts rules allowing pharmaceutical companies to license drugs from Chinese biotech firms. Learn how new regulations affect US-China ...
Johnson & Johnson's Caplyta (lumateperone) shows significant efficacy in bipolar I disorder mania. Phase III trial results presented at Psych Congress 2026.
Siemens Healthineers and Novo collaborate to expand non-invasive blood-based testing for MASLD and MASH. Learn about this healthcare partnership.
Earendil Labs partners with Genentech for AI-designed bispecific antibodies in oncology. $1.5B+ deal includes $55M upfront payment and milestone targets.
Otsuka's ulefnersen becomes first drug to meet primary endpoint in placebo-controlled FUS-ALS trial, targeting rare genetic ...
Viking's VK2735 sustains 97% weight loss with monthly injections. Discover how this GLP-1/GIP agonist offers flexible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results